Zervixkarzinom

  • H. G. Meerpohl
Chapter

Zusammenfassung

Häufigkeit: In USA und Mitteleuropa sind derzeit ca. 2,6% aller Karzinome der Frau invasive Zervixkarzinome, und bei ca. 3% aller malignombedingten Todesfälle ist das invasive Zervixkarzinom die Ursache. Damit ist das Zervixkarzinom in diesen Ländern nur noch das sechsthäufigste Malignom der Frau nach dem Mammakarzinom, den kolorektalen Karzinomen, dem Endometriumkarzinom, dem Bronchialkarzinom und dem Ovarialkarzinom, während weltweit das invasive Zervixkarzinom nach wie vor den 2. Rang einnimmt.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Barron BA, Richart RM (1970) Statistical model of the natural history of cervical carcinoma. II. Estimates of the transit time from dysplasia to carcinoma in situ. Proc Natl Cancer Inst 45: 1075Google Scholar
  2. Bommel P van et al. (1987) A review of prognostic factors in early stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy. Eur J Obstet Gynecol Reprod Biol 26: 69–84PubMedCrossRefGoogle Scholar
  3. Bonomi P, Blessing JA, Stehman FB et al. (1985) Radomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 3: 1079–1085PubMedGoogle Scholar
  4. Bonomi P, Blessing J, Ball H et al. (1989) A phase II evaluation of cisplatin and 5fluorouracil in patients with advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Gynecol Oncol 34: 357–359PubMedCrossRefGoogle Scholar
  5. Burghardt E, Pickel H (1978) Local spread and lymphnode involvement in cervical cancer. Obstet Gynecol 52: 138PubMedGoogle Scholar
  6. Burghardt E, Giardi F, Lahousen M et al. (1991) Microinvasive carcinoma of the uterine cervix ( International Federation of Gynecology and Obstestrics Stage IA ). Cancer 67: 1037PubMedCrossRefGoogle Scholar
  7. Buxton EJ, Meanwell CA, Hilton C, Mould JJ (1989) Combination bleomycin, ifosfamid and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 81: 359–361PubMedCrossRefGoogle Scholar
  8. Buxton EJ, Saunders N, Blackledge GRP et al. (1990) The potential for adjuvant therapy in early stage cervical cancer. Cancer Chemother Pharmacol 26 [Suppl]: 17–21CrossRefGoogle Scholar
  9. Dall P, Meerpohl HG, Henne K, duBois A et al. (1996) Combined radiochemotherapy in advanced cervical cancer: a phase II trial with weekly applied carboplatin, 5-fluorouracil and folinic acid. Int J Gynecol Cancer 6: 20–26CrossRefGoogle Scholar
  10. Delgado G, Bundy B, Zaino R et al. (1990) Prospective surgical pathologic study of diseasefree interval in patients with stagie IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38: 352PubMedCrossRefGoogle Scholar
  11. Gallion HN, Nagel JR van, Donaldsen GS et al. (1985) Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel shaped cervical cancer. Cancer 56: 262–265PubMedCrossRefGoogle Scholar
  12. Hausen H zur (1991) Viruses in human cancer. Science 254: 1167–1173PubMedCrossRefGoogle Scholar
  13. Homesley HD, Raben M, Blake DD et al. (1980) Relationship of lesion size to survival in patients with stage Ib squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Oncol 150: 529–531Google Scholar
  14. Hopkins MP, Morley GW (1991) Squamous cell cancer of the cervix: prognostic factors related to survuval. Int J Gynecol Cancer 1: 173CrossRefGoogle Scholar
  15. Kavanagh J, Wallace S, Declos L et al. (1984) Update of results of intra-arterial chemotherapy for advanced squamous cell carcinoma of the cervix. Proc ASCO 3: 172Google Scholar
  16. Kinney WK, Alvarez RD, Reid GC et al. (1989) Value of adjuvant whole pelvis irradiation after Wertheim — hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study. Gynecol Oncol 34: 258–262PubMedCrossRefGoogle Scholar
  17. Kjorstad KE, Martimbeau PW, Iversen T (1983) Stage IB carcinoma of the cervix: The Norwegian Radium Hospital results and complications. III Urinary and gastrointestinal complications. Gynecol Oncol 15: 42–47Google Scholar
  18. Kolstadt P, Valborg K (1976) Long term follow up to 1121 cases of carcinoma in situ. Obstet Gynecol 48: 125Google Scholar
  19. Kühnle H, Meerpohl HG, Eiermann Wet al. (1990) Phase II study of carboplatin/ ifosfamide in untreated advanced cervical cancer. Cancer Chemother Pharmacol 26: 33–35CrossRefGoogle Scholar
  20. Kumar L, Bargava VL (1991) Chemotherapy in recurrent and advanced cervical cancer. Gynecol Oncol 40: 107–111PubMedCrossRefGoogle Scholar
  21. Marcial VAm Amato D, Marks RD (1983) Split-course versus continuous pelvis irradiation in carcinoma of the uterine cervix: A prospective randomized clinical trial of the Radiation Therapy. Oncolgy Group Int J Radiat Oncol Biol Phys 9: 431–436Google Scholar
  22. Meepohl HG, Eiermann W, Achterrath W, Kühnle H (1990) Chemotherapie zur Remissionsinduktion bei fortgeschrittenem Zervixkarzinom der FIGO-Stadien IIb—IVb. Erste Ergebnisse einer Phase-Il-Studie mit Carboplatin/Ifosfamid. In: Teufel G, Pfleiderer A, Ladner HA (Eds) Therapie des Zervixkarzinoms. Springer, Berlin Heidelberg New York Tokyo, 298–306CrossRefGoogle Scholar
  23. Morley GW, Seski JC (1976) Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gyncol 126: 785–798Google Scholar
  24. Morrow CP (1980) Panel report: Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 10: 105–110CrossRefGoogle Scholar
  25. Nagell JR van, Greenwell N, Powell DF et al. (1983) Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 145: 981PubMedGoogle Scholar
  26. Nelson Aj, Fletcher GH, Wharton T (1975) Indications for adjunctive conservative extrafascial hysterectomy in selected cases of carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Med 123: 91–96CrossRefGoogle Scholar
  27. Newton M (1979) Radical hysterektomy or radiationtherapy for stage I cervical cancer. Am J Obstet Gynecol 123: 535–542Google Scholar
  28. Papanicolaou GN, Traut HF (1941) The diagnostic value of vaginal smears in carcinomas of the uterus. Am J Obstet Gynecol 42: 193Google Scholar
  29. Perez CA, Kao MS (1985) Radiation therapy alone or combined with surgery in barrel shaped carcinoma of the uterine cervix (Stages IB, II a, IIB). Int J Radiat Oncol Biol Phys 11: 1903–1909CrossRefGoogle Scholar
  30. Perez CA, Camel HM, Kao MS et al. (1987) Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: Final Report. Gynecol Oncol 27: 129–140PubMedCrossRefGoogle Scholar
  31. Piver MS, Wallace S, Castro JR (1971) The accuracy of lymphangiography in carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Nucl Med 111: 278PubMedCrossRefGoogle Scholar
  32. Piver MS, Barlow JJ, Vongtama V et al. (1977) Hydroxeurea as a radiation sensitizer in women with carcinoma of the uterine cervix. A randomized double blind study. Am J Obstet Gynecol 129: 379–383PubMedGoogle Scholar
  33. Scarabelli C, Tumulo S, de Paoli A et al. (1987) Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 60: 25–30PubMedCrossRefGoogle Scholar
  34. Stehman F, Bundy BN, diSaia PJ (1991) Carcinoma of the cervix treated with radiation therapy: a multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67: 2776PubMedCrossRefGoogle Scholar
  35. Sutton GP, Blessing J, McGuire W, Patton T (1991) Phase II trial of ifosfamide and mesna in chemotherapy naive patients with recurrent or advanced squamous carcinoma of the cervix. Proc Soc Gynecol Oncol Feb 1991Google Scholar
  36. Tattersall MHN, Ramirez C, Coppelson M (1992) A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage I B-II A cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 46: 176–181PubMedCrossRefGoogle Scholar
  37. Vermorken JB (1993) The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer 3: 129–142PubMedCrossRefGoogle Scholar
  38. Vermorken JB, Colombo N, van der Burg MEL et al. (1992) Combination chemotherapy of bleomycin (B), cindesine (E), mitomycin (M) and cisplatin (BEMP) versus single agent cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix (SCCUC): A phase III trial. Proc ESMO 12: November 1992 abstract # 0705Google Scholar
  39. Wong LC, Choo YC, Choy D et al. (1989) Long term follow up of potentiation of radiotherapy by cisplatinum in advanced cervical cancer. Gynecol Oncol 35: 159–163PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • H. G. Meerpohl

There are no affiliations available

Personalised recommendations